| Tretinoin | Approved Investigational Nutraceutical | KLK7 | 5650 |
upregulated | Tretinoin results in increased expression of KLK7 mRNA | 19q13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | KMT2A | 4297 |
downregulated | Tretinoin results in decreased expression of KMT2A mRNA | 11q23.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KPNA1 | 3836 |
upregulated | Tretinoin results in increased expression of KPNA1 mRNA | 3q21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | KPNA2 | 3838 |
downregulated | Tretinoin results in decreased expression of KPNA2 mRNA | 17q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KPNB1 | 3837 |
downregulated | Tretinoin results in decreased expression of KPNB1 mRNA | 17q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | KREMEN1 | 83999 |
upregulated | Tretinoin results in increased expression of KREMEN1 mRNA | 22q12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | KREMEN2 | 79412 |
downregulated | Tretinoin results in decreased expression of KREMEN2 mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT1 | 3848 |
upregulated | Tretinoin metabolite results in increased expression of KRT1 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT1 | 3848 |
downregulated | Tretinoin results in decreased expression of KRT1 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT10 | 3858 |
upregulated | Tretinoin metabolite results in increased expression of KRT10 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT10 | 3858 |
downregulated | Tretinoin results in decreased expression of KRT10 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT10 | 3858 |
upregulated | Tretinoin results in increased expression of KRT10 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT13 | 3860 |
downregulated | Tretinoin results in decreased expression of KRT13 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT13 | 3860 |
upregulated | Tretinoin results in increased expression of KRT13 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT14 | 3861 |
upregulated | Tretinoin metabolite results in increased expression of KRT14 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT14 | 3861 |
downregulated | Tretinoin results in decreased expression of KRT14 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT14 | 3861 |
upregulated | Tretinoin results in increased expression of KRT14 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT15 | 3866 |
upregulated | Tretinoin metabolite results in increased expression of KRT15 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT15 | 3866 |
upregulated | Tretinoin results in increased expression of KRT15 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT17 | 3872 |
upregulated | Tretinoin metabolite results in increased expression of KRT17 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT17 | 3872 |
downregulated | Tretinoin results in decreased expression of KRT17 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT18 | 3875 |
upregulated | Tretinoin results in increased expression of KRT18 mRNA | 12q13.13 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT19 | 3880 |
upregulated | Tretinoin metabolite results in increased expression of KRT19 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT19 | 3880 |
upregulated | Tretinoin results in increased expression of KRT19 mRNA | 17q21.2 | |
| Tretinoin | Approved Investigational Nutraceutical | KRT2 | 3849 |
upregulated | Tretinoin results in increased expression of KRT2 mRNA | 12q13.13 | |